Moderna shares surge after CEO says sales growth expected in 2025
Moderna MRNA-Q shares rose more than 11 per cent on Tuesday after the vaccine maker’s CEO Stéphane Bancel said in a shareholder letter that the company expects its sales to grow in 2025. “With the expected launch of our RSV vaccine candidate in 2024, and potential launch of our flu/COVID…
#modernamrnaq #stéphanebancel #rsv #bancel